What Do You See As The Most Significant Regulatory Decision Or Guidance On The Horizon For 2024 (Or Beyond)?
Pharma's Almanac,
Robert Nass, Head of Quality
Robert Nass, Head of Quality
Jared Schuster, Senior Regulatory Affairs Associate, Be The Match BioTherapies In 2023, the FDA released the draft guidance…
pm EST| By Deborah Abrams Kaplan As of November 2022, over a million Americans have lost their lives due to COVID-19, and more…